|
|
Volumn 2, Issue 5, 2002, Pages 293-296
|
|
Pharmacogenetics research network and knowledge base second scientific meeting
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTINEOPLASTIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
DRUG METABOLIZING ENZYME;
IRINOTECAN;
LEUKOTRIENE RECEPTOR AFFECTING AGENT;
MORPHINE;
ORPHAN DRUG;
PAROXETINE;
RAMIPRIL;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SIMVASTATIN;
TAMOXIFEN;
WARFARIN;
YOHIMBINE;
ARTICLE;
ASTHMA;
BIOTECHNOLOGY;
CLINICAL TRIAL;
COLORECTAL CANCER;
DNA MICROARRAY;
DRUG COST;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG RESPONSE;
DRUG TRANSPORT;
ETHNOLOGY;
GENETIC VARIABILITY;
GENOTYPE;
HOT FLUSH;
HUMAN;
HYPERLIPIDEMIA;
LONG QT SYNDROME;
MEMBRANE TRANSPORT;
NEUTROPENIA;
OUTCOMES RESEARCH;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
SINGLE NUCLEOTIDE POLYMORPHISM;
THROMBOEMBOLISM;
CONFERENCE PAPER;
GENETIC DATABASE;
GENOME;
HEALTH CARE ORGANIZATION;
LEGAL ASPECT;
METHODOLOGY;
PHARMACOGENETICS;
UNITED STATES;
DATABASES, GENETIC;
GENOME, HUMAN;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PHARMACOGENETICS;
UNITED STATES;
|
|
EID: 0036450511
PISSN: 1470269X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.tpj.6500125 Document Type: Article |
|
Times cited : (3)
|
|
References (10)
|
